HIV drug B/F/TAF tested in pregnancy for safety and virus control
Disease control
ENROLLING_BY_INVITATION
This study looks at the safety and effectiveness of the HIV medication B/F/TAF in pregnant women who have had their virus under control for at least six months. About 50 women in their first trimester will continue taking the drug through pregnancy and 12 weeks after birth. Resea…
Sponsor: Shi Zou • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC